Skip to main content
OpenTrials

Clinical trial condition

Haemophilus Infections

Explore clinical trials studying Haemophilus Infections. Study availability and eligibility vary by location and protocol.

158 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Haemophilus Infections trial results

Completed

Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A

NCT00839254

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Ear Diseases, +11 more
Locations
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Jarvenpaa, Finland
View all 15 locations
View Trial Details
Completed

Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™

NCT00907777

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
  • GSK Investigational Site Nördlingen, Bavaria, Germany
  • GSK Investigational Site Bad Oeynhausen, North Rhine-Westphalia, Germany
  • GSK Investigational Site Goch, North Rhine-Westphalia, Germany
View all 17 locations
View Trial Details
Completed

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination

NCT00985751

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations
  • GSK Investigational Site Chomutov, Czechia
  • GSK Investigational Site Děčín, Czechia
  • GSK Investigational Site Náchod, Czechia
  • GSK Investigational Site Odolena Voda, Czechia
View Trial Details
Completed

Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

NCT01453998

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations
  • GSK Investigational Site Santo Domingo, Dominican Republic
  • GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
View all 16 locations
View Trial Details
Completed

Evaluation of an Infant Immunization Encouragement Program in Nigeria

NCT03870061

Conditions
Actinomycetales Infections, Arbovirus Infections, Bacterial Infections, +55 more
Locations
  • Primary Health Care facilities across Jigawa State Various Cities, Jigawa State, Nigeria
  • Primary Health Care facilities across Katsina State Various Cities, Katsina State, Nigeria
  • Primary Health Care facilities across the Zamfara State Various Cities, Zamfara State, Nigeria
View Trial Details

Related conditions